PMC:7376845 / 556-755
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T3","span":{"begin":3,"end":10},"obj":"Body_part"},{"id":"T4","span":{"begin":181,"end":188},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"(S protein), which interacts with ACE2, appear conserved in SARS-CoV-2.\n\nAim\nThe cross-reactivity with SARS-CoV-2 of monoclonal antibodies (mAbs) previously generated against the S protein of SARS-Co"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"19","span":{"begin":1,"end":10},"obj":"Gene"},{"id":"20","span":{"begin":34,"end":38},"obj":"Gene"},{"id":"27","span":{"begin":60,"end":70},"obj":"Species"},{"id":"33","span":{"begin":179,"end":180},"obj":"Gene"},{"id":"35","span":{"begin":103,"end":113},"obj":"Species"}],"attributes":[{"id":"A20","pred":"tao:has_database_id","subj":"20","obj":"Gene:59272"},{"id":"A27","pred":"tao:has_database_id","subj":"27","obj":"Tax:2697049"},{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"Gene:43740568"},{"id":"A35","pred":"tao:has_database_id","subj":"35","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"(S protein), which interacts with ACE2, appear conserved in SARS-CoV-2.\n\nAim\nThe cross-reactivity with SARS-CoV-2 of monoclonal antibodies (mAbs) previously generated against the S protein of SARS-Co"}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T17","span":{"begin":60,"end":68},"obj":"Disease"},{"id":"T18","span":{"begin":60,"end":64},"obj":"Disease"},{"id":"T19","span":{"begin":103,"end":111},"obj":"Disease"},{"id":"T20","span":{"begin":103,"end":107},"obj":"Disease"},{"id":"T22","span":{"begin":192,"end":196},"obj":"Disease"}],"attributes":[{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A20","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"(S protein), which interacts with ACE2, appear conserved in SARS-CoV-2.\n\nAim\nThe cross-reactivity with SARS-CoV-2 of monoclonal antibodies (mAbs) previously generated against the S protein of SARS-Co"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T7","span":{"begin":73,"end":76},"obj":"http://purl.obolibrary.org/obo/PR_000001343"}],"text":"(S protein), which interacts with ACE2, appear conserved in SARS-CoV-2.\n\nAim\nThe cross-reactivity with SARS-CoV-2 of monoclonal antibodies (mAbs) previously generated against the S protein of SARS-Co"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T4","span":{"begin":3,"end":10},"obj":"Chemical"},{"id":"T5","span":{"begin":181,"end":188},"obj":"Chemical"}],"attributes":[{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"(S protein), which interacts with ACE2, appear conserved in SARS-CoV-2.\n\nAim\nThe cross-reactivity with SARS-CoV-2 of monoclonal antibodies (mAbs) previously generated against the S protein of SARS-Co"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T7","span":{"begin":73,"end":76},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"(S protein), which interacts with ACE2, appear conserved in SARS-CoV-2.\n\nAim\nThe cross-reactivity with SARS-CoV-2 of monoclonal antibodies (mAbs) previously generated against the S protein of SARS-Co"}